MannKind | 销售成本

Cost Of Sales 更改 日
Adma Biologics USD 42.82M 195K 2023-12
Dynavax Technologies USD 8.69M 4.54M 2023-12
Halozyme Therapeutics USD 52.3M 2.52M 2023-12
Insmed USD 18.44M 1.74M 2023-12
MannKind USD 18.07M 3.81M 2023-12
Novo Nordisk DKK 9.71B 1.86B 2023-09
Pfizer USD 6.66B 2.24B 2023-12



MannKind 销售成本 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.